282 related articles for article (PubMed ID: 10086082)
1. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
Badawy SZ; Marziale JC; Rosenbaum AE; Chang JK; Joy SE
Early Pregnancy; 1997 Dec; 3(4):306-11. PubMed ID: 10086082
[TBL] [Abstract][Full Text] [Related]
2. Prolactinomas and pregnancy.
Bronstein MD
Pituitary; 2005; 8(1):31-8. PubMed ID: 16411066
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of prolactinomas.
Molitch ME
Adv Intern Med; 1999; 44():117-53. PubMed ID: 9929707
[No Abstract] [Full Text] [Related]
4. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
[TBL] [Abstract][Full Text] [Related]
5. Macroprolactinoma expansion during pregnancy.
Trivedi N; Mithal A
J Assoc Physicians India; 1993 Nov; 41(11):738-9. PubMed ID: 8005934
[No Abstract] [Full Text] [Related]
6. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.
Ahmed M; al-Dossary E; Woodhouse NJ
Fertil Steril; 1992 Sep; 58(3):492-7. PubMed ID: 1521641
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma].
Jin ZM; Shi YF; Chen GL
Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):669-72, 702-3. PubMed ID: 2086009
[TBL] [Abstract][Full Text] [Related]
8. Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.
Iyer P; Molitch ME
Endocr Pract; 2011; 17(3):e55-8. PubMed ID: 21324816
[TBL] [Abstract][Full Text] [Related]
9. CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.
Dietemann JL; Portha C; Cattin F; Mollet E; Bonneville JF
Neuroradiology; 1983; 25(3):133-8. PubMed ID: 6888713
[TBL] [Abstract][Full Text] [Related]
10. Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.
Morange I; Barlier A; Pellegrini I; Brue T; Enjalbert A; Jaquet P
Eur J Endocrinol; 1996 Oct; 135(4):413-20. PubMed ID: 8921822
[TBL] [Abstract][Full Text] [Related]
11. Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment.
Saeki N; Nakamura M; Sunami K; Yamaura A
Endocr J; 1998 Aug; 45(4):529-37. PubMed ID: 9881903
[TBL] [Abstract][Full Text] [Related]
12. Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.
Brue T; Pellegrini I; Gunz G; Morange I; Dewailly D; Brownell J; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 1992 Mar; 74(3):577-84. PubMed ID: 1346788
[TBL] [Abstract][Full Text] [Related]
13. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
14. Relative resistance of a macroprolactinoma to bromocriptine therapy during pregnancy.
Shanis BS; Check JH
Gynecol Endocrinol; 1996 Apr; 10(2):91-4. PubMed ID: 8701792
[TBL] [Abstract][Full Text] [Related]
15. Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patients.
Jamrozik SI; Bennet AP; James-Deidier A; Tremollieres F; Saint-Martin F; Dumoulin S; Valat-Coustols M; de Glisezinski I; Tremoulet M; Manelfe C; Louvet JP
J Endocrinol Invest; 1996; 19(7):472-9. PubMed ID: 8884542
[TBL] [Abstract][Full Text] [Related]
16. [Effects of bromocriptine on the treatment of prolactinomas in male patients and its influences on their sexual function].
Xue XC; Jiang S; Yin SL; Zhong CH; Zhou PZ; Cheng SW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):452-7. PubMed ID: 23898534
[TBL] [Abstract][Full Text] [Related]
17. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
Barrera CM; Ruiz AE; Banks WA
Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
[TBL] [Abstract][Full Text] [Related]
18. Gender-related differences in prolactin secretion in pituitary prolactinomas.
Nishioka H; Haraoka J; Akada K; Azuma S
Neuroradiology; 2002 May; 44(5):407-10. PubMed ID: 12012125
[TBL] [Abstract][Full Text] [Related]
19. Giant prolactinomas: clinical management and long-term follow up.
Shrivastava RK; Arginteanu MS; King WA; Post KD
J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal.
Passos VQ; Souza JJ; Musolino NR; Bronstein MD
J Clin Endocrinol Metab; 2002 Aug; 87(8):3578-82. PubMed ID: 12161478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
